Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.03
0.01 (0.98%)
At close: Aug 15, 2025, 3:59 PM
1.03
0.00%
After-hours: Aug 15, 2025, 07:10 PM EDT

Clearmind Medicine Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
26.7K 26.7K 26.7K 19.15K 21.87K 32.44K 51.14K 83.03K 125.29K 119.93K 113.38K 80.09K 19.93K 14.71K 2.57K n/a n/a n/a
Gross Profit
-26.7K -26.7K -26.7K -19.15K -21.87K -32.44K -51.14K -83.03K -125.29K -119.93K -113.38K -80.09K -19.93K -14.71K -2.57K n/a n/a n/a
Operating Income
-5.86M -6.26M -6.3M -4.24M -3.97M -3.49M -3.78M -5.83M -6.47M -8.28M -8.53M -9.27M -8.5M -5.66M -3.68M -1.45M -434.04K -306.93K
Interest Income
252.35K 244.66K 271.22K 197.19K 129.47K 101.48K 58.92K 41.28K 30.58K 24.62K 6.6K 6.6K n/a n/a n/a n/a n/a n/a
Pretax Income
-4.63M -4.74M -4.88M -7.04M -5.42M -6.07M -6.74M -5.88M -7.46M -9.12M -9.37M -9.82M -8.88M -5.9M -3.9M -1.45M -434.04K -306.93K
Net Income
-4.83M -4.96M -5.25M -7.33M -5.66M -6.28M -6.76M -6.42M -8.18M -10.12M -10.37M -10.27M -9.16M -5.89M -3.9M -1.45M -434.04K -306.93K
Selling & General & Admin
4.11M 4.23M 4.35M 4.21M 3.71M 3.71M 3.81M 3.86M 4.63M 5.09M 5.48M 6.21M 5.84M 4.58M 3.03M 1.38M 434.04K 306.93K
Research & Development
1.74M 1.61M 1.38M 1.17M 1.02M 931.2K 1.3M 1.56M 1.8M 3.15M 2.98M 3.04M 2.66M 1.07M 646.49K 57.26K n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 35.85K 96.02K 101.24K 113.38K 77.52K 17.36K 12.14K n/a 4.91K n/a n/a
Operating Expenses
5.83M 5.83M 5.72M 5.39M 4.76M 4.67M 5.14M 5.45M 6.53M 8.34M 8.58M 9.33M 8.51M 5.67M 3.68M 1.45M 434.04K 306.93K
Interest Expense
52.74K 44.88K 36.16K 6K 5.99K 5.99K 5.99K 4.48K 19.68K 163.19K 173.66K 392.38K 377.2K 233.68K 223.22K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.69M 2.68M 2.57M 5.4M 4.76M 4.67M 5.14M 5.45M 6.53M 8.34M 8.58M 9.33M 8.51M 5.67M 3.68M 1.45M 434.04K 306.93K
Income Tax Expense
199.7K 215.8K 377.97K 289.09K 241.54K 211.6K 13.51K 548.67K 718.8K 999.02K 1M 684.34K 465.17K 122.34K 58.2K -220.15K -218.9K -214.21K
Shares Outstanding (Basic)
5.04M 4.49M 4.27M 3.56M 3.25M 1.52M 3.56M 2.36M 1.25M 765.91K 439.92K 439.91K 436.37K 417.26K 420K 350K 210K 210K
Shares Outstanding (Diluted)
5.04M 4.49M 4.27M 3.56M 3.25M 1.52M 3.56M 2.36M 1.25M 765.91K 439.92K 439.91K 436.37K 417.26K 426.23K 355.79K 214.28K 213.61K
EPS (Basic)
-1.2 -1.31 -1.98 -13.21 -15.05 -31.4 -54.31 -79.11 -112.44 -153.24 -168.99 -181 -169.99 -119.57 -83.59 -38 -16.9 -12.5
EPS (Diluted)
-1.2 -1.31 -1.98 -13.21 -15.05 -31.4 -54.31 -79.11 -112.44 -153.24 -168.99 -181 -169.99 -119.57 -83.59 -38 -16.9 -12.5
EBITDA
-4.94M -5.33M -5.85M -5.77M -5.4M -5.35M -5.63M -6.1M -6.8M -8.04M -8.3M -9.04M -8.34M -5.65M -3.68M -1.45M -362.6K -173.78K
EBIT
-4.99M -4.99M -5.35M -5.25M -4.88M -5.24M -5.69M -5.85M -5.79M -5.85M -5.65M -6.26M -6.09M -4.52M -2.97M -1.16M -341.44K -232.11K
Depreciation & Amortization
50.71K 54.48K 51.07K 43.52K 46.24K 41.07K 51.14K 83.03K 125.29K 119.93K 113.38K 80.09K 73.93K 124.52K 167.59K 220.15K 218.9K 214.21K